PHRM.L Regulatory News (PHRM)

19 June 2012

Phorm, Inc. ('Phorm' or 'the Company')

AGM Result

At the Annual General Meeting ("AGM") of the Company held today, all the resolutions contained in the Notice of Meeting and put to the meeting were duly passed.

Consequentially Andrew Croxson and Christophe Delorme were elected as directors of the Company.

Additional information

Under Schedule 2, paragraph (g) of the AIM Rules, the following information is disclosed: In the past five years Andrew James Croxson, aged 39, has previously been a director of Sprawl Technologies Limited. Mr Croxson does not have any existing directorships. Mr Croxson has confirmed there is no additional information under Schedule 2, paragraph (g) of the AIM rules which needs to be disclosed.

Under Schedule 2, paragraph (g) of the AIM Rules, the following information is disclosed: Christophe Delorme, aged 45, is currently a director of RSR Capital pte Ltd and Sapiance Capital Limited. Mr Delorme has confirmed there is no additional information under Schedule 2, paragraph (g) of the AIM rules which needs to be disclosed.

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

- ends -

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com